CFDE Data Portal | Search C1QL2

	Label	Description
	C1QL2 associations Collection (Entity type)	Associations for C1QL2_associations
	C1QL2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	C1QL2 Gene (Entity type)	ENSG00000144119 - complement C1q like 2
	GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 8 V 1 AZACITIDINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE217115 2 V 0 ALECTINIB MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226525 GSE226527 HNRNPH2 knockout 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

C1QL2 associations

Associations for C1QL2_associations

C1QL2 associations.tsv

A file from IDG as part of the Harmonizome project

C1QL2

ENSG00000144119 - complement C1q like 2

GSE205729,GSE205731 2 V 3 TAZEMETOSTAT HUMAN UP

A Gene Set from LINCS

GSE108464 AZ-628 11 v 12 human up

A Gene Set from LINCS

GSE176008 8 V 1 AZACITIDINE HUMAN DN

A Gene Set from LINCS

GSE217115 2 V 0 ALECTINIB MOUSE DN

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 15 human up

A Gene Set from LINCS

GSE226525 GSE226527 HNRNPH2 knockout 4 v 5 human up

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.